TNFA

TNF Pharmaceuticals, Inc. Common Stock
TNFA

Overview Fund Activity

35 hedge funds and large institutions have $6.95M invested in TNF Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+3
Holders Change %
+9.38%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
5
Closed
5
Calls
$195K
Puts
$164K
Net Calls
+$31K
Net Calls Change
-$25K

Top Buyers

1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$718K
2
Wells Fargo
Wells Fargo
California
+$129K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.2K
4
Group One Trading
Group One Trading
Illinois
+$44.6K
5
PA
Parallel Advisors
California
+$43.2K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$246K
2
SC
Shay Capital
New York
-$238K
3
Millennium Management
Millennium Management
New York
-$79K
4
IAIM
International Assets Investment Management
Florida
-$77.1K
5
Two Sigma Investments
Two Sigma Investments
New York
-$34.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
51
Millennium Management
New York
– -$79K -23 Closed
IAIM
52
International Assets Investment Management
Florida
– -$77.1K -22 Closed
Two Sigma Investments
53
Two Sigma Investments
New York
– -$34.6K -10 Closed
UBS Group
54
UBS Group
Switzerland
– -$8.41K -2 Closed
IA
55
IFP Advisors
Florida
– -$1K – –
1 2
3